Cargando…
Instructive Role of the Microenvironment in Preventing Renal Fibrosis
Accumulation of myofibroblasts is a hallmark of renal fibrosis. A significant proportion of myofibroblasts has been reported to originate via endothelial‐mesenchymal transition. We initially hypothesized that exposing myofibroblasts to the extract of endothelial progenitor cells (EPCs) could reverse...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442777/ https://www.ncbi.nlm.nih.gov/pubmed/28297566 http://dx.doi.org/10.5966/sctm.2016-0095 |
_version_ | 1783238465967620096 |
---|---|
author | Matsumoto, Kei Xavier, Sandhya Chen, Jun Kida, Yujiro Lipphardt, Mark Ikeda, Reina Gevertz, Annie Caviris, Mario Hatzopoulos, Antonis K. Kalajzic, Ivo Dutton, James Ratliff, Brian B. Zhao, Hong Darzynkiewicz, Zbygniew Rose‐John, Stefan Goligorsky, Michael S. |
author_facet | Matsumoto, Kei Xavier, Sandhya Chen, Jun Kida, Yujiro Lipphardt, Mark Ikeda, Reina Gevertz, Annie Caviris, Mario Hatzopoulos, Antonis K. Kalajzic, Ivo Dutton, James Ratliff, Brian B. Zhao, Hong Darzynkiewicz, Zbygniew Rose‐John, Stefan Goligorsky, Michael S. |
author_sort | Matsumoto, Kei |
collection | PubMed |
description | Accumulation of myofibroblasts is a hallmark of renal fibrosis. A significant proportion of myofibroblasts has been reported to originate via endothelial‐mesenchymal transition. We initially hypothesized that exposing myofibroblasts to the extract of endothelial progenitor cells (EPCs) could reverse this transition. Indeed, in vitro treatment of transforming growth factor‐β1 (TGF‐β1)‐activated fibroblasts with EPC extract prevented expression of α‐smooth muscle actin (α‐SMA); however, it did not enhance expression of endothelial markers. In two distinct models of renal fibrosis—unilateral ureteral obstruction and chronic phase of folic acid‐induced nephropathy—subcapsular injection of EPC extract to the kidney prevented and reversed accumulation of α‐SMA‐positive myofibroblasts and reduced fibrosis. Screening the composition of EPC extract for cytokines revealed that it is enriched in leukemia inhibitory factor (LIF) and vascular endothelial growth factor. Only LIF was capable of reducing fibroblast‐to‐myofibroblast transition of TGF‐β1‐activated fibroblasts. In vivo subcapsular administration of LIF reduced the number of myofibroblasts and improved the density of peritubular capillaries; however, it did not reduce the degree of fibrosis. A receptor‐independent ligand for the gp130/STAT3 pathway, hyper‐interleukin‐6 (hyper‐IL‐6), not only induced a robust downstream increase in pluripotency factors Nanog and c‐Myc but also exhibited a powerful antifibrotic effect. In conclusion, EPC extract prevented and reversed fibroblast‐to‐myofibroblast transition and renal fibrosis. The component of EPC extract, LIF, was capable of preventing development of the contractile phenotype of activated fibroblasts but did not eliminate TGF‐β1‐induced collagen synthesis in cultured fibroblasts and models of renal fibrosis, whereas a receptor‐independent gp130/STAT3 agonist, hyper‐IL‐6, prevented fibrosis. In summary, these studies, through the evolution from EPC extract to LIF and then to hyper‐IL‐6, demonstrate the instructive role of microenvironmental cues and may provide in the future a facile strategy to prevent and reverse renal fibrosis. Stem Cells Translational Medicine 2017;6:992–1005 |
format | Online Article Text |
id | pubmed-5442777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54427772017-06-15 Instructive Role of the Microenvironment in Preventing Renal Fibrosis Matsumoto, Kei Xavier, Sandhya Chen, Jun Kida, Yujiro Lipphardt, Mark Ikeda, Reina Gevertz, Annie Caviris, Mario Hatzopoulos, Antonis K. Kalajzic, Ivo Dutton, James Ratliff, Brian B. Zhao, Hong Darzynkiewicz, Zbygniew Rose‐John, Stefan Goligorsky, Michael S. Stem Cells Transl Med Translational Research Articles and Reviews Accumulation of myofibroblasts is a hallmark of renal fibrosis. A significant proportion of myofibroblasts has been reported to originate via endothelial‐mesenchymal transition. We initially hypothesized that exposing myofibroblasts to the extract of endothelial progenitor cells (EPCs) could reverse this transition. Indeed, in vitro treatment of transforming growth factor‐β1 (TGF‐β1)‐activated fibroblasts with EPC extract prevented expression of α‐smooth muscle actin (α‐SMA); however, it did not enhance expression of endothelial markers. In two distinct models of renal fibrosis—unilateral ureteral obstruction and chronic phase of folic acid‐induced nephropathy—subcapsular injection of EPC extract to the kidney prevented and reversed accumulation of α‐SMA‐positive myofibroblasts and reduced fibrosis. Screening the composition of EPC extract for cytokines revealed that it is enriched in leukemia inhibitory factor (LIF) and vascular endothelial growth factor. Only LIF was capable of reducing fibroblast‐to‐myofibroblast transition of TGF‐β1‐activated fibroblasts. In vivo subcapsular administration of LIF reduced the number of myofibroblasts and improved the density of peritubular capillaries; however, it did not reduce the degree of fibrosis. A receptor‐independent ligand for the gp130/STAT3 pathway, hyper‐interleukin‐6 (hyper‐IL‐6), not only induced a robust downstream increase in pluripotency factors Nanog and c‐Myc but also exhibited a powerful antifibrotic effect. In conclusion, EPC extract prevented and reversed fibroblast‐to‐myofibroblast transition and renal fibrosis. The component of EPC extract, LIF, was capable of preventing development of the contractile phenotype of activated fibroblasts but did not eliminate TGF‐β1‐induced collagen synthesis in cultured fibroblasts and models of renal fibrosis, whereas a receptor‐independent gp130/STAT3 agonist, hyper‐IL‐6, prevented fibrosis. In summary, these studies, through the evolution from EPC extract to LIF and then to hyper‐IL‐6, demonstrate the instructive role of microenvironmental cues and may provide in the future a facile strategy to prevent and reverse renal fibrosis. Stem Cells Translational Medicine 2017;6:992–1005 John Wiley and Sons Inc. 2016-10-05 2017-03 /pmc/articles/PMC5442777/ /pubmed/28297566 http://dx.doi.org/10.5966/sctm.2016-0095 Text en © 2016 The Authors Stem Cells Translational Medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Translational Research Articles and Reviews Matsumoto, Kei Xavier, Sandhya Chen, Jun Kida, Yujiro Lipphardt, Mark Ikeda, Reina Gevertz, Annie Caviris, Mario Hatzopoulos, Antonis K. Kalajzic, Ivo Dutton, James Ratliff, Brian B. Zhao, Hong Darzynkiewicz, Zbygniew Rose‐John, Stefan Goligorsky, Michael S. Instructive Role of the Microenvironment in Preventing Renal Fibrosis |
title | Instructive Role of the Microenvironment in Preventing Renal Fibrosis |
title_full | Instructive Role of the Microenvironment in Preventing Renal Fibrosis |
title_fullStr | Instructive Role of the Microenvironment in Preventing Renal Fibrosis |
title_full_unstemmed | Instructive Role of the Microenvironment in Preventing Renal Fibrosis |
title_short | Instructive Role of the Microenvironment in Preventing Renal Fibrosis |
title_sort | instructive role of the microenvironment in preventing renal fibrosis |
topic | Translational Research Articles and Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442777/ https://www.ncbi.nlm.nih.gov/pubmed/28297566 http://dx.doi.org/10.5966/sctm.2016-0095 |
work_keys_str_mv | AT matsumotokei instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT xaviersandhya instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT chenjun instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT kidayujiro instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT lipphardtmark instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT ikedareina instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT gevertzannie instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT cavirismario instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT hatzopoulosantonisk instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT kalajzicivo instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT duttonjames instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT ratliffbrianb instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT zhaohong instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT darzynkiewiczzbygniew instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT rosejohnstefan instructiveroleofthemicroenvironmentinpreventingrenalfibrosis AT goligorskymichaels instructiveroleofthemicroenvironmentinpreventingrenalfibrosis |